Roche Touts Benefit Of Health Economic Data For Targeted Cancer Therapies
This article was originally published in The Pink Sheet Daily
Executive Summary
Reimbursement for Genentech's Avastin indicates the value of health economic data, Roche Worldwide Pharmaceuticals Head William Burns said